Syncromune™
Joe Gerardi has a extensive work experience in finance and leadership roles. Their most recent position was as the Chief Financial Officer at Syncromune™ starting from December 2020. Prior to that, they founded and served as the Chief Executive Officer of Fox Hollow Financial Consulting, LLC, where they provided financial strategies and capital management solutions for companies in the MedTech Market Place. Joe was also an Executive Vice President, Chief Financial Officer, Treasurer, and Secretary at ImmunSYS, Inc. from January 2018 to August 2020.
Joe Gerardi has held various executive roles in finance, including Vice President and Chief Financial Officer at Advanced Vascular Resources, LLC, Vice President and Chief Operating Officer/Chief Financial Officer at Centinel Spine, Inc., Vice President and Chief Financial Officer at Knee Creations, LLC, and Vice President and Chief Financial Officer at Paradigm Spine LLC. Joe has also worked as a Vice President of Special Projects and Chief Financial Officer at ANGIODYNAMICS Inc.
Before their executive roles, Joe Gerardi started their career as a Cost Accountant at FACTRON/Schlumberger and later served as a Plant Controller at Mallinckrodt.
Joe Gerardi's education history begins in 1980 when they attended Mohonasen High School. It is unclear when they completed their high school education as there are no specific start and end years provided. After high school, Joe went on to pursue higher education.
From 1980 to 1982, Joe enrolled at SUNY Cobleskill, where they obtained an Associate's Degree in Accounting and Finance. During the same period, they also attended the State University of New York at Cobleskill, where they earned an Associates of Applied Science degree in Accounting.
Joe continued their education at SUNY Polytechnic Institute from 1982 to 1984 and completed their Bachelor of Business Administration (B.B.A.) with a specialization in Finance. Simultaneously, they attended the University at Albany, SUNY, where they obtained a Master of Business Administration (M.B.A.) degree in International Business from 1980 to 1984.
Regarding additional certifications, Joe holds an MBA from the University at Albany School of Business, although specific information about the obtained month and year is not available.
This person is not in any teams
This person is not in any offices
Syncromune™
1 followers
Syncromune™ is a privately held, clinical stage biopharmaceutical company dedicated to the development of better immunotherapies for metastatic solid tumor cancers. We are at the forefront of developing combination immunotherapies, which several thought leaders consider to be the future of cancer therapy. We are committed to bringinglife-changing treatments to patients with unmet medical needs by fighting cancer in a new way. The company is currently developing Syncrovax™, a proprietary platform technology that uses a combination approach to synchronize the timing and location of tumor antigen release with the functional activation and education of immune cells. An in situ vaccine is created from the patient’s own tumor antigens, making it a personalized treatment for each patient. The platform is designed to optimize T cells and the immune system to treat metastatic solid tumors where other therapies have failed.